PEOPLE - UroGenesys (US) makes appointment:
This article was originally published in Clinica
Executive Summary
UroGenesys has appointed Mary Anderson director of business development. Ms Anderson joins the US developer of urological cancer diagnostics and therapeutics from Bayer's NAD diagnostics division.